Reuters Health Report

Click to View in Browser 03/27/2014 GSK recalls weight-loss drug Alli in U.S. after tampering LONDON (Reuters) - GlaxoSmithKline is recalling all supplies of its non-prescription weight-loss drug Alli in the United States and Puerto Rico, the company said on Thursday, after reports that some bottles had been tampered with. FDA approves William Demant hearing aid against tinnitus COPENHAGEN (Reuters) - William Demant has received approval for its first hearing aid reducing tinnitus from the United States Food and Drug Administration (FDA), the Danish company told Reuters on Thursday. India declared polio-free, but global risks persist NEW DELHI, March 27 (Thomson Reuters Foundation) - The World Health Organisation declared India free of the crippling polio virus on Thursday, making the country's almost two-decade-long, multi-billion-dollar effort one of the biggest public health achievements in recent times. Hospital ratings show sharp differences in safety, chance of dying NEW YORK (Reuters) - An analysis of government data on hospital safety, including how likely patients are to die of avoidable surgical complications, shows that hospitals vary markedly on these measures and that patients are at higher risk in some nationally-known facilities than at tiny hospitals little known outside their rural communities. Novartis says lung cancer patients respond to drug in study ZURICH (Reuters) - Novartis said late on Wednesday that a majority of patients given a development drug against non-small cell lung cancer had responded to the treatment, according to study results published in the New England Journal of Medicine. Alimera makes fourth bid for eye treatment approval from FDA (Reuters) - Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients. Australia demands opponents stop stalling WTO tobacco case GENEVA (Reuters) - Australia asked five countries challenging its tobacco policies on Wednesday to stop delaying the progress of their cases at the World Trade Organization and took the unusual step of speeding up one of the complaints against itself. Baxter plans to spin off biotech business in 2015 (Reuters) - Baxter International Inc said on Thursday that it would spin off its biotechnology operations into a publicly traded company by the middle of next year and focus on its core medical technology business, sending its shares up more than 7 percent. China regulators order end to smog insurance sales SHANGHAI (Reuters) - Chinese regulators have told the country's two largest insurers to stop selling coverage against smog, a week after such policies were launched, the China Daily reported on Thursday. Planned Parenthood, Arizona in court over abortion drug rules TUCSON, Arizona (Reuters) - Arizona regulations that would limit the use of the most popular abortion-inducing drug risk harming women seeking to end their pregnancies, attorneys for a women's health provider argued in federal court in Tucson on Wednesday. Related Video Birds show signs of Texas oil spill Lima youth ride wave of eco-awareness with bottle boards The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend